CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Ashish Kacholia's Secret Small-Cap Pharma Stock Gets Green Light for European Export
DSIJ Intelligence
/ Categories: Trending, Mindshare

Ashish Kacholia's Secret Small-Cap Pharma Stock Gets Green Light for European Export

The stock gave multibagger returns of 280 per cent in 5 years whereas BSE small-cap index is up by 65 per cent.

Today, shares of IOL Chemicals & Pharmaceuticals jumped 2.56 per cent to an intraday high of Rs 408.50 per share. At the closing bell, shares of the company were in green, up 2.27 per cent to Rs 407.35 per share.  

IOL Chemicals & Pharmaceuticals Ltd informed that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a “Certificate of Suitability for Paracetamol” on May 3, 2023. This will enable the Company to export Paracetamol in European Market.  

 

DSIJ offers a product 'Tiny Treasure' with recommendations for small-cap & micro-cap stocks based on research and analysis to help subscribers make informed investment decisions. If this interests you, then do download the product details pdf here

 

IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the speciality chemicals space. It serves the domestic and export market.   

Talking about the financials, this BSE Small-Cap company has a market cap of Rs 2,391.37 crore. The company reported positive numbers in its Quarterly Results and annual results. The net sales rose by 3 per cent and net profit skyrocketed 133 per cent in Q4FY23 over Q4FY22. In FY23, net sales rose by 11 per cent over FY22.   

The stock gave multibagger returns of 280 per cent in 5 years whereas BSE small-cap index is up by 65 per cent. Investors should keep an eye on this pharma stock.   

Previous Article This multinational tyre company to give 1,680 per cent dividend for FY23!
Next Article Stocks to watch: These small-cap stocks will be in focus on Friday!
Print
12796 Rate this article:
4.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR